These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 24780410

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Strontium ranelate in the prevention of osteoporotic fractures.
    Reginster JY, Malaise O, Neuprez A, Bruyere O.
    Int J Clin Pract; 2007 Feb; 61(2):324-8. PubMed ID: 17263720
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Strontium ranelate's (Osseor) dual mode of action: increasing bone mass and decreasing bone resorption].
    Kaliterna DM.
    Reumatizam; 2008 Feb; 55(2):73-4. PubMed ID: 19024281
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [The efficacy of strontium ranelate (Osseor) on fractures in osteoporosis].
    Novak S.
    Reumatizam; 2008 Feb; 55(2):75-7. PubMed ID: 19024282
    [Abstract] [Full Text] [Related]

  • 29. Cost-effectiveness of strontium ranelate for the prevention and treatment of osteoporosis.
    Hiligsmann M, Vanoverberghe M, Neuprez A, Bruyère O, Reginster JY.
    Expert Rev Pharmacoecon Outcomes Res; 2010 Aug; 10(4):359-66. PubMed ID: 20715911
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Strontium ranelate may cause alopecia.
    Sainz M, del Pozo JG, Arias LH, Carvajal A.
    BMJ; 2009 Apr 22; 338():b1494. PubMed ID: 19386675
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Hemorheological changes with strontium ranelate treatment do not seem to be related to its claimed prothrombotic effects.
    Ulger Z, Gurel EI, Halil M, Oozen G, Kalan I, Seringec N, Yavuz BB, Yesil Y, Cankurtaran M, Dikmenoglu N, Ariogul S.
    Arch Gerontol Geriatr; 2012 Apr 22; 54(1):218-21. PubMed ID: 21167612
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Incidence of venous thromboembolism in users of strontium ranelate: an analysis of data from a prescription-event monitoring study in England.
    Osborne V, Layton D, Perrio M, Wilton L, Shakir SA.
    Drug Saf; 2010 Jul 01; 33(7):579-91. PubMed ID: 20553059
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Strontium ranelate: vertebral and non-vertebral fracture risk reduction.
    Seeman E.
    Curr Opin Rheumatol; 2006 Jun 01; 18 Suppl 1():S17-20. PubMed ID: 16735841
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.